Back
  1. Home
  2. Profile of Mégane Willems (ULiège)
Profil

Willems Mégane

GIGA Cancer - Cellular and Molecular Epigenetics

Département GxABT > Microbial technologies

See author's contact details
ORCID
0000-0003-0319-5600
Main Referenced Co-authors
Willems, Luc  (8)
Hamaïdia, Malik  (6)
Brossel, Hélène  (4)
Fontaine, Alexis  (4)
Jamakhani, Majeed  (4)
Main Referenced Keywords
chemotherapy (6); mesothelioma (6); eosinophils (5); Eosinophils (2); Mesothelioma (2);
Main Referenced Disciplines
Oncology (10)
Immunology & infectious disease (1)

Publications (total 10)

The most downloaded
146 downloads
Willems, M. (2023). Eosinophils inhibit response to chemotherapy: mechanisms, preclinical and clinical study in mesothelioma [Doctoral thesis, ULiège. GxABT - Liège Université. Gembloux Agro-Bio Tech]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/306186 https://hdl.handle.net/2268/306186

The most cited

4 citations (Scopus®)

Brossel, H., Fontaine, A., Hoyos, C., Jamakhani, M., Willems, M., Hamaïdia, M., & Willems, L. (2021). Activation of DNA Damage Tolerance Pathways May Improve Immunotherapy of Mesothelioma. Cancers, 13, 3211. doi:10.3390/cancers13133211 https://hdl.handle.net/2268/267149

Willems, M. (2023). Eosinophils inhibit response to chemotherapy: mechanisms, preclinical and clinical study in mesothelioma [Doctoral thesis, ULiège. GxABT - Liège Université. Gembloux Agro-Bio Tech]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/306186

Willems, M. (27 June 2023). In vitro, preclinical and patients’ data evidence for a role of eosinophils in mesothelioma response to chemotherapy [Paper presentation]. International Mesothelioma interest Group, Lille, France.
Peer reviewed

Willems, M., & Willems, L. (08 February 2023). Eosinophils inhibit response to therapy: mechanisms and preclinical study in mesothelioma [Paper presentation]. GIGA-Cancer seminars, Liège, Belgium.

Willems, M., Scherpereel, A., Wasielewski, E., Raskin, J., Brossel, H., Fontaine, A., Grégoire, M., Halkin, L., Jamakhani, M., Heinen, V., Louis, R., Duysinx, B., Hamaïdia, M.* , & Willems, L.*. (2023). Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesothelioma. Frontiers in Immunology, 14, 1148798. doi:10.3389/fimmu.2023.1148798
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Hoyos, C., Fontaine, A., Brossel, H., Willems, M., Jamakhani, M., Vandermeers, F., Safari, R., HEINEN, V., LOUIS, R., DUYSINX, B., Scherpereel, A., Wasielewski, E., Mascaux, C., Hamaïdia, M.* , & Willems, L.*. (14 December 2021). Contribution of lysine deacetylases to the therapy of malignant pleural mesothelioma [Poster presentation]. Giga Cancer Day, Liège, Belgium.
* These authors have contributed equally to this work.

Willems, M., Jamakhani, M., Scherpereel, A., Wasielewski, E., Brossel, H., Fontaine, A., Hoyos, C., Grégoire, M., Louis, R., Duysinx, B., Hamaïdia, M.* , & Willems, L.*. (14 December 2021). Eosinophils inhibit malignant pleural mesothelioma response to chemotherapy [Poster presentation]. GIGA-Cancer Day, Liège, Belgium.
* These authors have contributed equally to this work.

Brossel, H., Fontaine, A., Hoyos, C., Jamakhani, M., Willems, M., Hamaïdia, M., & Willems, L. (2021). Activation of DNA Damage Tolerance Pathways May Improve Immunotherapy of Mesothelioma. Cancers, 13, 3211. doi:10.3390/cancers13133211
Peer Reviewed verified by ORBi

Willems, M., & Willems, L. (20 November 2020). Eosinophils inhibit mesothelioma chemotherapy [Paper presentation]. GIGA-Cancer Seminars, Liège, Belgium.

Willems, M., Willems, L., & Hamaïdia, M. (November 2019). Influence des éosinophiles sur la réponse des cellules de mésothéliome pleural malin à la chimiothérapie [Poster presentation]. 2èmes Journées Francophones sur le Mésothéliome, Nantes, France.

Willems, M., Willems, L., & Hamaïdia, M. (November 2019). Influence des éosinophiles sur la réponse des cellules de mésothéliome pleural malin à la chimiothérapie [Paper presentation]. 2ème Journées Francophones sur le Mésothéliome, Nantes, France.

Contact ORBi